stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Return on assets
Schrodinger, Inc.'s return on assets over the twelve months to 30 September 2026 was −9.36%, up 4.0 percentage points from fiscal 2025 (−13.3%). Over the past ten years it has ranged from −47.1% (fiscal 2018) to 5.46% (fiscal 2023); the current reading is higher than 78% of that period. That is below the Health Information Services industry median of −5.62% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −13.3% | 9.68 |
| FY2024 | −23.0% | (28.47) |
| FY2023 | 5.46% | 26.11 |
| FY2022 | −20.7% | (7.29) |
| FY2021 | −13.4% | (7.93) |
| FY2020 | −5.43% | 12.38 |
| FY2019 | −17.8% | 29.28 |
| FY2018 | −47.1% | (27.63) |
| FY2017 | −19.5% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| HSTM HealthStream, Inc. compare | 3.84% |
| PRVA Privia Health Group, Inc. compare | 2.38% |
| OMCL Omnicell, Inc. compare | 2.23% |
| OMDA Omada Health, Inc. compare | 1.36% |
| GDRX GoodRx Holdings, Inc. compare | 0.89% |
| CERT Certara, Inc. compare | −4.36% |
| TDOC Teladoc Health, Inc. compare | −5.48% |
| SDGR Schrodinger, Inc. | −9.36% |
| HTFL Heartflow, Inc. compare | −47.0% |
| Health Information Services industry median | −5.62% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement